Molecular mechanisms of bifunctional vitamin D receptor agonist-histone deacetylase inhibitor hybrid molecules in triple-negative breast cancer.

Autor: Barbier C; Departments of Physiology, McGill University, Montreal, QC, Canada., Mansour A; Departments of Chemistry, McGill University, Montreal, QC, Canada., Ismailova A; Departments of Physiology, McGill University, Montreal, QC, Canada., Sarmadi F; Departments of Physiology, McGill University, Montreal, QC, Canada., Scarlata DA; Departments of Chemistry, McGill University, Montreal, QC, Canada., Bouttier M; Departments of Physiology, McGill University, Montreal, QC, Canada., Zeitouni C; Departments of Physiology, McGill University, Montreal, QC, Canada., Wang C; Departments of Physiology, McGill University, Montreal, QC, Canada., Gleason JL; Departments of Chemistry, McGill University, Montreal, QC, Canada. jim.gleason@mcgill.ca., White JH; Departments of Physiology, McGill University, Montreal, QC, Canada. john.white@mcgill.ca.; Departments of Medicine, McGill University, Montreal, QC, Canada. john.white@mcgill.ca.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2022 Apr 25; Vol. 12 (1), pp. 6745. Date of Electronic Publication: 2022 Apr 25.
DOI: 10.1038/s41598-022-10740-9
Abstrakt: The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), and its analogues signal through the nuclear vitamin D receptor (VDR), a ligand-regulated transcription factor, and have been extensively investigated as anticancer agents. 1,25D and its analogs have potential in combination therapies because they exhibit synergistic activities with other anticancer agents such as histone deacetylase inhibitors (HDACi). We have developed a series of hybrid molecules that combine HDACi within the backbone of a VDR agonist and thus represent fully integrated bifunctional molecules. They exhibit anti-tumor efficacy in reducing tumor growth and metastases in an aggressive model of triple-negative breast cancer. However, their solubility is limited by their hydrophobic diarylpentane cores. Our goals here were two-fold: (1) to improve the solubility of hybrids by introducing nitrogen into diarylpentane cores, and (2) to investigate the molecular mechanisms underlying their anti-tumor efficacy by performing comparative gene expression profiling studies with 1,25D and the potent HDACi suberoylanilide hydroxamic acid (SAHA). We found that substituting aryl with pyrydyl rings did not sacrifice bifunctionality and modestly improved solubility. Notably, one compound, AM-193, displayed enhanced potency as a VDR agonist and in cellular assays of cytotoxicity. RNAseq studies in triple negative breast cancer cells revealed that gene expression profiles of hybrids were very similar to that of 1,25D, as was that observed with 1,25D and SAHA combined. The effects of SAHA alone on gene expression were limited and distinct from those 1,25D or hybrids. The combined results suggest that efficacy of hybrids arises from targeting HDACs that do not have a direct role in gene regulation. Moreover, pathways analysis revealed that hybrids regulate numerous genes controlling immune cell infiltration into tumors and suppress the expression of several secreted molecules that promote breast cancer growth and metastasis.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje